In their CMAJ editorial, Flegel and Fletcher1 call for a national dialogue on end-of-life care,
arguing that policy change should not be the result of a single court decision. 1 In Canada …

We wish to correct the inaccuracies in the CMAJ article by Tibbetts1 on Quebec's end-of-life
bill. Tibbetts writes…“hospitals in Quebec and the rest of Canada often offer palliative …

Published at www. cmaj. ca on Feb. 5, 2009. ramipril6 or harms of using proton pump
inhibitors in combination with clopidogrel7 in patients at risk of cardiovascular death were …

Rassen and colleagues recently reported an analysis of a potentially clinically significant
clopidogrel–proton pump inhibitor interaction among patients presenting with acute …

In their CMAJ editorial, Flegel and Fletcher1 call for a national dialogue on end-of-life care,
arguing that policy change should not be the result of a single court decision. 1 In Canada …

We agree with Harvey White and Chris Ellis (http://www. nzma. org. nz/journal/119-
1228/1808/) 1 that clopidogrel would be effective and, relative to other potential investments …

Berger Proton Pump Inhibitors and Clopidogrel 7 clopidogrel, aspirin and clopidogrel, or
triple therapy (aspirin, clopidogrel, and an anticoagulant), rather than administered too …

Michelle O'Donoghue and collea g ues' post-hoc analysis of TRITON-TIMI 38 and
PRINCIPLE-TIMI 44 (Sept 19, p 989) 1 suggests that use of a protonpump inhibitor (PPI) …

ciation (AHA) convened a writing committee. The ACCF and AHA adhere to a rigorous policy
regarding relationships with industry and other entities (RWI) of authors and peer reviewers …

Drs Potter and Le Lorier note that a large number of patients in our study had no recorded
clopidogrel use within 7 days of hospital discharge. 1 We believe the primary cause of the …